Stock MGRX MANGOCEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Real-time Estimate Cboe BZX
Other stock markets
 02:28:40 2024-05-23 pm EDT 		5-day change 1st Jan Change
0.538 USD +16.96% Intraday chart for Mangoceuticals, Inc. +131.03% +83.64%
May. 21 Sector Update: Health Care Stocks Advance Late Afternoon MT
May. 21 Sector Update: Health Care MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
AQ
Sector Update: Health Care Stocks Advance Late Afternoon
MT
Sector Update: Health Care
MT
Top Midday Gainers
MT
MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications
AQ
MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration
AQ
Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
AQ
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
AQ
Mangoceuticals Signs Securities Purchase Deal; Mexican Unit Enters Technical Deal With Emifarma
MT
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
AQ
Mangoceuticals, Inc. announced that it expects to receive CAD 1.5 million in funding from Platinum Point Capital LLC
CI
Certain Warrants of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2024.
CI
Certain Options of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2024.
CI
Certain Common Stock of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 21-MAR-2024.
CI
Top Premarket Gainers
MT
Certain Common Stock of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-MAR-2024.
CI
Certain Warrants of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-MAR-2024.
CI
Certain Options of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-MAR-2024.
CI
MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MGRX Stock
  4. News Mangoceuticals, Inc.